Synopsis of recent research by authors named "Alvaro Juarez"
Alvaro Juarez's recent research primarily focuses on prostate cancer, including diagnostic accuracy, treatment strategies, and adaptations in management related to COVID-19.
His studies include the validation of the Select MDx test for high-grade prostate cancer detection in biopsy-naïve patients and the final survival analysis of the TITAN study, which demonstrated the efficacy of apalutamide in treating metastatic castration-sensitive prostate cancer.
Additionally, Juarez has addressed the challenges posed by the COVID-19 pandemic on prostate cancer management, providing recommendations based on limited evidence and expert experiences across various regions.
